Lutz Heinemann

Summary

Publications

  1. pmc Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 5:681-6. 2011
  2. pmc Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes
    Christoph Kapitza
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    Diabetes Care 33:1288-90. 2010
  3. pmc AP@home: a novel European approach to bring the artificial pancreas home
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 5:1363-72. 2011
  4. pmc Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion
    Christoph Kapitza
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 4:123-31. 2010
  5. pmc Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 4:750-3. 2010
  6. pmc Biosimilar insulins: how similar is similar?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 5:741-54. 2011
  7. pmc Lancing: quo vadis?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 5:966-81. 2011
  8. doi Oral insulin reloaded: a structured approach
    Eric Zijlstra
    Profil, Neuss, Germany
    J Diabetes Sci Technol 8:458-65. 2014
  9. doi Quality of glucose measurement with blood glucose meters at the point-of-care: relevance of interfering factors
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Hellersbergstrasse 9, Neuss, Germany
    Diabetes Technol Ther 12:847-57. 2010
  10. pmc Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, GmbH, Neuss, Germany
    J Diabetes Sci Technol 3:1490-500. 2009

Collaborators

Detail Information

Publications10

  1. pmc Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 5:681-6. 2011
    ..Evaluation of postprandial glycemic excursions in patients with type 1 diabetes with three prandial insulins: VIAject™ (Linjeta™), an ultra-fast insulin (UFI); insulin lispro (LIS); and regular human insulin (RHI)...
  2. pmc Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes
    Christoph Kapitza
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    Diabetes Care 33:1288-90. 2010
    ..To determine the pharmacokinetic and pharmacodynamic properties of an oral insulin (OI) formulation compared with subcutaneously injected regular human insulin (RHI)...
  3. pmc AP@home: a novel European approach to bring the artificial pancreas home
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 5:1363-72. 2011
    ....
  4. pmc Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion
    Christoph Kapitza
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 4:123-31. 2010
    ..The aim of this study was to assess glucose changes during and after physical exercise in patients with type 1 diabetes managed by continuous subcutaneous insulin infusion before and after a 14-day moderate or intense exercise program...
  5. pmc Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, Neuss, Germany
    J Diabetes Sci Technol 4:750-3. 2010
    ..Nevertheless, it is impressive to see how often metabolic control improves considerably once the patients apply the insulin into other skin areas...
  6. pmc Biosimilar insulins: how similar is similar?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 5:741-54. 2011
    ....
  7. pmc Lancing: quo vadis?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
    J Diabetes Sci Technol 5:966-81. 2011
    ..This may have a greater impact on metabolic control than many of the new and expensive antidiabetic drugs...
  8. doi Oral insulin reloaded: a structured approach
    Eric Zijlstra
    Profil, Neuss, Germany
    J Diabetes Sci Technol 8:458-65. 2014
    ..While this picture clearly reflects the rising research interest in orally bioavailable insulin formulations, it also highlights the fact that the lion's share of research efforts is still allocated to the preclinical stages. ..
  9. doi Quality of glucose measurement with blood glucose meters at the point-of-care: relevance of interfering factors
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung GmbH, Hellersbergstrasse 9, Neuss, Germany
    Diabetes Technol Ther 12:847-57. 2010
    ..This depends on the application in which meters designed for self-monitoring of BG (SMBG) are used...
  10. pmc Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?
    Lutz Heinemann
    Profil Institut für Stoffwechselforschung, GmbH, Neuss, Germany
    J Diabetes Sci Technol 3:1490-500. 2009
    ..Therefore, the recommendation made in most of these studies (i.e., use of dual-wave bolus) has to be accepted with care, until we have better evidence...